Article ID Journal Published Year Pages File Type
7864696 Journal of Controlled Release 2014 8 Pages PDF
Abstract
A combination treatment of intratumoral interleukin-12 gene therapy, metronomic cyclophosphamide and genetic vaccination results in 89% cure rate in a melanoma mouse model.66
Keywords
Related Topics
Physical Sciences and Engineering Materials Science Biomaterials
Preview
Combination of interleukin-12 gene therapy, metronomic cyclophosphamide and DNA cancer vaccination directs all arms of the immune system towards tumor eradication
Authors
, , , ,